Combined cytogenotoxic effects of bee venom and bleomycin on rat lymphocytes: An in vitro study

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Abd Elhakim, Yasmina M ^a   Khalil, Samah R ^a   Awad, Ashraf ^a   Al Ayadhi, Laila Y ^b,c  

^a Zagazig University   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c Autism Research and Treatment Center   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BEE VENOM; BLEOMYCIN; CASPASE 3; LACTATE DEHYDROGENASE; PROTEIN BCL 2; CYTOTOXIN; MUTAGENIC AGENT;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOTOXICITY; DENSITY GRADIENT CENTRIFUGATION; DNA DAMAGE; DNA FRAGMENTATION; DNA FRAGMENTATION ASSAY; DOWN REGULATION; ENZYME RELEASE; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENOTOXICITY; LYMPHOCYTE; MORPHOMETRICS; MTT ASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; CELL CULTURE; DRUG EFFECTS; MALE; METABOLISM; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; BEE VENOMS; BLEOMYCIN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOTOXINS; DNA FRAGMENTATION; L-LACTATE DEHYDROGENASE; LYMPHOCYTES; MALE; MUTAGENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84900026889     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/173903     Document Type: Article

References (52)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA: Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
2. Ferguson L. R., Pearson A. E., The clinical use of mutagenic anticancer drugs. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 1996 355 1-2 1 12 2-s2.0-0029838904 10.1016/0027-5107(96)00019-X
3. Santos R. A. D., Takahashi C. S., Anticlastogenic and antigenotoxic effects of selenomethionine on doxorubicin-induced damage in vitro in human lymphocytes. Food and Chemical Toxicology 2008 46 2 671 677 2-s2.0-37349121396 10.1016/j.fct.2007.09.090
4. Bhanot A., Sharma R., Noolvi M. N., Natural sources as potential anti-cancer agents: a review. International Journal of Phytomedicine 2011 3 1 9 26 2-s2.0-79960323899
5. Gajski G., Garaj-Vrhovac V., Bee venom induced cytogenetic damage and decreased cell viability in human white blood cells after treatment in vitro: a multi-biomarker approach. Environmental Toxicology and Pharmacology 2011 32 2 201 211 2-s2.0-80051582297 10.1016/j.etap.2011.05.004
6. Park H. J., Lee S. H., Son D. J., Oh K. W., Kim K. H., Song H. S., Kim G. J., Oh G. T., Yoon D. Y., Hong J. T., Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF- B through interaction with the p50 subunit. Arthritis and Rheumatism 2004 50 11 3504 3515 2-s2.0-8444239358 10.1002/art.20626
7. Roh D. H., Kwon Y. B., Kim H. W., Ham T., Yoon S., Kang S., Han H., Lee H., Beitz A. J., Lee J., Acupoint stimulation with diluted bee venom (apipuncture) alleviates thermal hyperalgesia in a rodent neuropathic pain model: involvement of spinal α 2-adrenoceptors. Journal of Pain 2004 5 6 297 303 2-s2.0-4444310546 10.1016/j.jpain.2004.05.003
8. Son D. J., Lee J. W., Lee Y. H., Song H. S., Lee C. K., Hong J. T., Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacology and Therapeutics 2007 115 2 246 270 2-s2.0-34447312502 10.1016/j.pharmthera.2007.04. 004
9. Oršolić N., Bee venom in cancer therapy. Cancer and Metastasis Reviews 2012 31 173 194
10. Vogel H., Incorporation of melittin into phosphatidylcholine bilayers. Study of binding and conformational changes. FEBS Letters 1981 134 1 37 42 2-s2.0-0019871670
11. Liu X., Chen D., Xie L., Zhang R., Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo. Journal of Pharmacy and Pharmacology 2002 54 8 1083 1089 2-s2.0-0035994880 10.1211/002235702320266235
12. Oršolić N., Šver L., Verstovšek S., Terzić S., Bašić I., Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon 2003 41 861 870 10.1016/S0041-0101(03)00045-X
13. Russell P. J., Hewish D., Carter T., Sterling-Levis K., Ow K., Hattarki M., Doughty L., Guthrie R., Shapira D., Molloy P. L., Werkmeister J. A., Kortt A. A., Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies. Cancer Immunology, Immunotherapy 2004 53 5 411 421 2-s2.0-2342464147 10.1007/s00262-003-0457-9
14. Liu S., Yu M., He Y., Xiao L., Wang F., Song C., Sun S., Ling C., Xu Z., Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 2008 47 6 1964 1973 2-s2.0-46249118135 10.1002/hep.22240
15. 2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells. Life Sciences 2007 80 4 364 369 2-s2.0-33845675375 10.1016/j.lfs.2006.09.024
16. Park M. H., Choi M. S., Kwak D. H., Oh K., Yoon D. Y., Han S. B., Song H. S., Song M. J., Hong J. T., Anti-cancer effect of bee venomin prostate cancer cells through activation of caspase pathway via inactivation of NF- B. Prostate 2011 71 8 801 812 2-s2.0-79953729368 10.1002/pros.21296
17. Park J. H., Jeong Y. J., Park K. K., Cho H., Chung I., Min K., Kim M., Lee K., Yeo J., Park K., Chang Y., Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF- B and AP-1-dependent MMP-9 expression. Molecules and Cells 2010 29 2 209 215 2-s2.0-77949425064 10.1007/s10059-010-0028-9
18. Gajski G., Garaj-Vrhovac V., Melittin: a lytic peptide with anticancer properties. Environmental Toxicolology and Pharmacology 2013 36 2 697 705 10.1016/j.etap.2013.06.009
19. Gajski G., Domijan A. M., Garaj-Vrhovac V., Alterations of GSH and MDA levels and their association with bee venom-induced DNA damage in human peripheral blood leukocytes. Environmental and Molecular Mutagenesis 2012 53 6 469 477 10.1002/em.21708
20. Chen J., Stubbe J., Bleomycins: towards better therapeutics. Nature Reviews Cancer 2005 5 2 102 112 2-s2.0-13444257678 10.1038/nrc1547
21. Froudarakis M., Hatzimichael E., Kyriazopoulou L., Revisiting BLM from pathophysiology to safe clinical use. Critical Reviews in Oncology/Hematology 2013 87 1 90 100 10.1016/j.critrevonc.2012.12.003
22. Sleijfer S., Bleomycin-induced pneumonitis. Chest 2001 120 2 617 624 2-s2.0-0034827655 10.1378/chest.120.2.617
23. Cloos J., Reid C. B. A., van der Sterre M. L. T., Tobi H., Leemans C. R., Snow G. B., Braakhuis B. J. M., A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects. Mutagenesis 1999 14 1 87 93 2-s2.0-0032941307 10.1093/mutage/14.1.87
24. Wallach-Dayan S. B., Izbicki G., Cohen P. Y., Gerstl-Golan R., Fine A., Breuer R., Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2006 290 4 L790 L796 2-s2.0-33646598090 10.1152/ajplung.00300.2004
25. Orsolić N., Potentiation of BLM lethality in HeLa and V79 cells by bee venom. Archives of Industrial Hygiene and Toxicology 2009 60 317 326
26. Schmidt J. O., Piek T., Chemistry, pharmacology and chemical ecology of ant venoms. Venoms of the Hymenoptera 1986 London, UK Academic Press 425 508
27. M'Bemba-Meka P., Lemieux N., Chakrabarti S. K., Role of oxidative stress, mitochondrial membrane potential, and calcium homeostasis in nickel sulfate-induced human lymphocyte death in vitro. Chemico-Biological Interactions 2005 156 1 69 80 2-s2.0-24944544334 10.1016/j.cbi.2005.07.004
28. Bounous D. I., Campagnoli R. P., Brown J., Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Diseases 1992 36 4 1022 1027 2-s2.0-0026937849
29. Fotakis G., Timbrell J. A., In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicology Letters 2006 160 2 171 177 2-s2.0-27644544444 10.1016/j.toxlet.2005.07.001
30. Duke R. C., Cohen J. J., Coligan J. E., Kruisbeal A. M., Morphological and biochemical assays of apoptosis. Current Protocols in Immunology 1992 New York, NY, USA John Wiley & Sons 1 3
31. Liles W. C., Dale D. C., Klebanoff S. J., Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995 86 8 3181 3188 2-s2.0-0028787397
32. Squier M. K. T., Cohen J. J., Calpain, an upstream regulator of thymocyte apoptosis. Journal of Immunology 1997 158 8 3690 3697 2-s2.0-0031569532
33. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262
34. Duncan D. B., Multiple ranges and multiple F-test. Biometrics 1995 11 1 42
35. Venkatachalam P., Jayanth V. R., Solomon F. D., Paul modifications of BLM induced cytogenetic damages by 2-deoxy-D-glucose on normal and tumor cells. International Journal of Human Genetics 2007 7 307 314
36. Jo M., Park M. H., Kollipara P. S., An B. J., Song H. S., Han S. B., Kim J. H., Song M. J., Hong J. T., Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicology and Applied Pharmacology 2012 258 1 72 81 2-s2.0-84855417569 10.1016/j.taap.2011.10.009
37. Park J. H., Kim K. H., Kim S. J., Lee W. R., Lee K. G., Park K. K., Bee venom protects hepatocytes from tumor necrosis factor- α and actinomycin D. Archives of Pharmacal Research 2010 33 2 215 223 2-s2.0-77949890358 10.1007/s12272-010-0205-6
38. Lee Y. J., Kang S. J., Kim B. M., Kim Y. J., Woo H. D., Chung H. W., Cytotoxicity of honeybee (Apis mellifera) venom in normal human lymphocytes and HL-60 cells. Chemico-Biological Interactions 2007 169 3 189 197 2-s2.0-34548321105 10.1016/j.cbi.2007.06.036
39. Gajski G., Cimbora-Zovko T., Osmak M., Garaj-Vrhovac V., Bee venom and melittin are cytotoxic against different types of tumor and non-tumor cell lines in vitro. Cancer Research Journal 2011 4 159 174
40. Kim K. H., Kum Y. S., Park Y. Y., Park J., Kim S., Lee W., Lee K., Han S., Park K., The protective effect of bee venom against ethanol-induced hepatic injury via regulation of the mitochondria-related apoptotic pathway. Basic and Clinical Pharmacology and Toxicology 2010 107 1 619 624 2-s2.0-77953857517 10.1111/j.1742-7843.2010.00549.x
41. Garaj-Vrhovac V., Gajski G., Evaluation of the cytogenetic status of human lymphocytes after exposure to a high concentration of bee venom in vitro. Archives of Industrial Hygiene and Toxicology 2009 60 1 27 34 2-s2.0-63849301135 10.2478/10004-1254-60-2009-1896
42. 2+-calmodulin complexed with bee venom melittin. Journal of Molecular Biology 1985 186 3 675 677 2-s2.0-0022419652
43. Weiss B., Wallace T. L., Cheung W. Y., Mechanism and pharmacological implications of altering calmodulin activity. Calcium and Cell Function 1980 1 New York, NY, USA Academic Press 329 379
44. Whitfield J. F., Boynton A. L., Macmanus J. P., Sikorska M., Tsang B. K., The regulation of cell proliferation by calcium and cyclic AMP. Molecular and Cellular Biochemistry 1979 27 3 155 179 2-s2.0-0018686281
45. Hong S. J., Rim G. S., Yang H. I., Yin C. S., Koh H. G., Jang M. H., Kim C. J., Choe B. K., Chung J. H., Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis. Toxicon 2005 46 1 39 45 2-s2.0-20444497923 10.1016/j.toxicon.2005.03.015
46. Son D. J., Ha S. J., Song H. S., Lim Y., Yun Y. P., Lee J. W., Moon D. C., Park Y. H., Park B. S., Song M. J., Hong J. T., Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor- B and Akt activation and enhancement of apoptotic protein expression. Journal of Pharmacology and Experimental Therapeutics 2006 317 2 627 634 2-s2.0-33645854059 10.1124/jpet.105.095901
47. Stuhlmeier K. M., Apis mellifera venom and melittin block neither NF- B-p50-DNA interactions nor the activation of NF- B, instead they activate the transcription of proinflammatory genes and the release of reactive oxygen intermediates. Journal of Immunology 2007 179 1 655 664 2-s2.0-34250861997
48. Ownby C. L., Powell J. R., Jiang M. S., Fletcher J. E., Melittin and phospholipase A2 from bee (Apis mellifera) venom cause necrosis of murine skeletal muscle in vivo. Toxicon 1997 35 1 67 80 2-s2.0-0030614390 10.1016/S0041-0101(96)00078-5
49. Poddevin B., Orlowski S., Belehradek J., Mir L. M., Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochemical Pharmacology 1991 42 S67 S75 2-s2.0-0025840591 10.1016/0006-2952(91) 90394-K
50. Ip S. W., Liao S. S., Lin S. Y., Lin J. P., Yang J. S., Lin M. L., Chen G. W., Lu H. F., Lin M. W., Han S. M., Chung J. G., The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7 cells. In Vivo 2008 22 2 237 246 2-s2.0-42149110945
51. Cohen G. M., Caspases: the executioners of apoptosis. Biochemical Journal 1997 326 1 1 16 2-s2.0-0030931876
52. Tu W. C., Wu C. C., Hsieh H. L., Chen C. Y., Hsu S. L., Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells. Toxicon 2008 52 2 318 329 2-s2.0-49449085608 10.1016/j.toxicon.2008.06.007